In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancer
Description
This study introduces a tailored COVID-19 model for patients with cancer, incorporating viral variants and immune-response dynamics. The model aims to optimize vaccination strategies, contributing to personalized healthcare for vulnerable groups.
